News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Courtagen Life Sciences, Inc. Releases epiSEEK™ World’s Most Comprehensive, Rapid, Next Generation Clinical Sequencing Test Targeting 327 Genes Associated With Epilepsy Phenotypes


10/31/2012 7:34:42 AM

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc. today announced the expansion of their molecular diagnostics menu. The new genetic test, epiSEEK™, provides the complete sequence of 327 genes that have been reported in association with epilepsy phenotypes and nonspecific seizure disorders.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES